Apoptosis and proliferation in paired primary colorectal adenocarcinomas and their liver metastases

Jinsil Seong, Jaeho Cho, Woo Ik Yang, Eun Ji Chung, Namkyu Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: % apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: % positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9% with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35±0.25, which was not statistically different from the 1.58±0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9±3.4 and 16.4± 2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.

Original languageEnglish
Pages (from-to)187-192
Number of pages6
JournalYonsei medical journal
Volume45
Issue number2
DOIs
Publication statusPublished - 2004 Apr 30

Fingerprint

Adenocarcinoma
Apoptosis
Neoplasm Metastasis
Liver
Neoplasms
Survival Rate
Survival
Colorectal Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{3b00df877809429ca6f602dbc8a488d3,
title = "Apoptosis and proliferation in paired primary colorectal adenocarcinomas and their liver metastases",
abstract = "The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: {\%} apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: {\%} positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9{\%} with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35±0.25, which was not statistically different from the 1.58±0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9±3.4 and 16.4± 2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.",
author = "Jinsil Seong and Jaeho Cho and Yang, {Woo Ik} and Chung, {Eun Ji} and Namkyu Kim",
year = "2004",
month = "4",
day = "30",
doi = "10.3349/ymj.2004.45.2.187",
language = "English",
volume = "45",
pages = "187--192",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "2",

}

Apoptosis and proliferation in paired primary colorectal adenocarcinomas and their liver metastases. / Seong, Jinsil; Cho, Jaeho; Yang, Woo Ik; Chung, Eun Ji; Kim, Namkyu.

In: Yonsei medical journal, Vol. 45, No. 2, 30.04.2004, p. 187-192.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Apoptosis and proliferation in paired primary colorectal adenocarcinomas and their liver metastases

AU - Seong, Jinsil

AU - Cho, Jaeho

AU - Yang, Woo Ik

AU - Chung, Eun Ji

AU - Kim, Namkyu

PY - 2004/4/30

Y1 - 2004/4/30

N2 - The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: % apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: % positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9% with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35±0.25, which was not statistically different from the 1.58±0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9±3.4 and 16.4± 2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.

AB - The proliferation potentials and the level of apoptosis were compared in paired primary colorectal adenocarcinomas and their liver metastases within each individual. From a total of 22 patients 44 specimens of paired primary and metastatic tumors were obtained for analysis. The levels of spontaneous apoptosis (a spontaneous apoptosis index, SAI: % apoptotic nuclei among a total of 1000 nuclei) and of proliferation (KI-67 index: % positively stained cells for KI-67 among a total of 1000 cells) were analyzed between primary and metastatic tumors. Survival rates and its relationship with the clinical parameters were also analyzed. The overall survival rate at 5 years was 16.9% with the median survival time of 45 months. T-stage (p=0.005) and time to liver metastasis (synchronous versus metachronous, p=0.03) showed statistical significance in relation to survival. The mean SAI of primary tumors was 1.35±0.25, which was not statistically different from the 1.58±0.18 of metastatic tumors (p=0.33). The mean KI-67 indices in primary and metastatic tumors were 23.9±3.4 and 16.4± 2.5, respectively, and this difference was statistically significant (p=0.016). Subset analysis showed significant difference in the KI-67 index in the synchronous group but not in the metachronous group. No significant difference was shown in the relative ratios of apoptosis to proliferation between the primary tumor and the metastasis within each individual. The results in this study may partly explain the indolent behavior of liver metastasis from colorectal cancer and provides a rationale for the active treatment of metastatic tumors as well as of primary disease.

UR - http://www.scopus.com/inward/record.url?scp=2442717544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442717544&partnerID=8YFLogxK

U2 - 10.3349/ymj.2004.45.2.187

DO - 10.3349/ymj.2004.45.2.187

M3 - Article

VL - 45

SP - 187

EP - 192

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 2

ER -